In the UK, there was a case where TGN1412, an immunotherapy under development, triggered a cytokine storm within hours of ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...
The University of Oxford is part of a £15.9 million UK-wide programme to develop human tumour tissue models, improving cancer ...
A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in the lab. Built from patient-derived stem cells and immune cells, it ...
A new 3D human brain tissue platform developed by MIT researchers is the first to integrate all major brain cell types, including neurons, glial cells and the vasculature into a single culture. Grown ...
Oct 28 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Tuesday it was collaborating with Nvidia (NVDA.O), opens new tab to build a supercomputer to help with drug discovery and shorten ...
The nonprofit said its new tool, using data from urine tests, has already picked up a spike of carfentanil, a potent and ...
A superbug that does not respond to the very last ditch antibiotics and that has been circulating in Asia and Europe arrives ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback